Regulatory Differences: EMA vs USFDA Long-Term Stability Requirements
Regulatory Differences: EMA vs USFDA Long-Term Stability Requirements EMA vs USFDA: Key Differences in Long-Term Stability Testing Requirements Long-term stability testing is an essential component of pharmaceutical development and lifecycle management. While both the European Medicines Agency (EMA) and the United States Food and Drug Administration (USFDA) operate under the principles of ICH Q1A(R2), their…
Read More “Regulatory Differences: EMA vs USFDA Long-Term Stability Requirements” »
